supply of procurement of medicines , ethamsylate 2 ml inj., 125 mg (item no. 1529 of ami 2026-27) ] , chloramphenicol 1% w/w applicap (item no. 2589 of ami 2026-27) ] , isosorbide mononitrate 20 mg tab/cap (item no. 1379 of ami 2026-27) ] , acyclovir 3% 5 gm ointment (item no. 1950 of ami 2026-27) ] , gentamicin 80 mg (40 mg/ ml) 2 ml inj (item no. 1111 of ami 2026-27) ] , risperidone 1 mg tab./cap. (item no. 1744 of ami 2026-27) ] , prednisolone 10 mg tab. (item no. 2328 of ami 2026-27) ] , lorazepam 1 mg tab. (item no. 1773 of ami 2026-27) ] , lorazepam 2 mg tab. (item no. 1774 of ami 2026-27) ] , dextrose 25% w/v inj. 100 ml (item no. 2378 of ami 2026-27) ] , diltiazem 25mg inj. (item no. 1370 of ami 2026-27) ] , nandrolone decanoate 25 mg/ml inj. (item no. 2318 of ami 2026-27) ] , atropine sulfate 0.6 mg/ml 1 ml amp inj. (item no. 1539 of ami 2026-27) ] , verapamil 40 mg tab. (item no. 1451 of ami 2026-27) ] , pentazocine lactate 30 mg per ml 1 ml amp. inj. (item no. 1590 of ami 2026-27) ] , phenytoin sodium 50 mg inj. (item no. 1629 of ami 2026-27) ] , buprenorphine hcl 0.3 mg/ml inj. (item no. 1587 of ami 2026-27) ]